Results 31 to 40 of about 1,473,215 (222)

Evaluation of autologous fat grafting in the treatment of juvenile localized scleroderma with facial involvement. [PDF]

open access: yesJ Scleroderma Relat Disord
Objectives: The objective of this study was to evaluate the effect of autologous fat grafting in patients with juvenile localized scleroderma with facial involvement.
Sander L   +5 more
europepmc   +2 more sources

A pilot study on ex vivo expanded autologous adipose‐derived stem cells of improving fat retention in localized scleroderma patients

open access: yesStem Cells Translational Medicine, 2021
In patients with localized scleroderma (LoS), facial deformity induced by subcutaneous atrophy greatly reduces life quality. Autologous fat grafting (AFG) is used for volume restoration but with low‐fat retention due to various reasons.
Chenyu Wang   +8 more
semanticscholar   +1 more source

Juvenile Localized Scleroderma from the Perspective of Pediatric Rheumatologist. Aspects of Diagnostics

open access: yesВопросы современной педиатрии, 2020
The localized scleroderma (morphea) is the clinical option of the juvenile scleroderma, the third in prevalence rheumatic condition in pediatrics. The article summarizes all the data on the classification, diagnostics, and differential diagnosis of ...
Rinat K. Raupov   +2 more
doaj   +1 more source

Localized scleroderma in children

open access: yesPrzegląd Dermatologiczny, 2020
Localized scleroderma is an autoimmune disease affecting the dermis and underlying tissues (subcutaneous tissue, fascia, muscles, bones). The disease mainly occurs in women aged 20–50 years; however, children aged 7–10 years represent about 15% of all ...
Katarzyna A. Wolska-Gawron   +1 more
doaj   +1 more source

Detection of autoimmune antibodies in localized scleroderma by synthetic oligonucleotide antigens. [PDF]

open access: yesPLoS ONE, 2018
In this study, we developed a series of synthetic oligonucleotides that allowed us to investigate the details on the antigen recognition by autoimmune antibodies in localized scleroderma subjects.
Simone Samuelsen   +4 more
doaj   +1 more source

Clinical periodontal diagnosis

open access: yesPeriodontology 2000, EarlyView., 2023
Abstract Periodontal diseases include pathological conditions elicited by the presence of bacterial biofilms leading to a host response. In the diagnostic process, clinical signs such as bleeding on probing, development of periodontal pockets and gingival recessions, furcation involvement and presence of radiographic bone loss should be assessed prior ...
Giovanni E. Salvi   +5 more
wiley   +1 more source

Mycophenolate mofetil for methotrexate-resistant juvenile localized scleroderma. [PDF]

open access: yesRheumatology (Oxford), 2021
Objectives To investigate safety and efficacy of MMF in patients with severe or MTX-refractory juvenile localized scleroderma. Methods Consecutive juvenile localized scleroderma patients undergoing systemic treatment were included in a retrospective ...
Martini G   +5 more
europepmc   +2 more sources

Systemic sclerosis with keloidal nodules [PDF]

open access: yesAnais Brasileiros de Dermatologia, 2013
Nodular sclerosis is a rare form of presentation related to both systemic and localized forms of scleroderma. We describe the case of a patient with nodular sclerosis in order to alert the medical community to recognize this entity.
Bárbara Stadler   +4 more
doaj   +1 more source

Narrow-Band Reflectance Spectrophotometry for the Assessment of Erythematous and Hyperpigmented Skin Lesions in Localized Scleroderma: A Preliminary Study

open access: yesClinical, Cosmetic and Investigational Dermatology, 2021
Background Localized scleroderma (LoS) is an inflammatory fibrosing disease of the connective tissue, whose esthetic sequelae are atrophic skin lesions with hyperpigmentation.
M. Szczepanek   +2 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy